Bioluminux Clinical Research — Naperville, Illinois

Bioluminux Clinical Research is a clinical research site located in Naperville, Illinois, United States 60540.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Bioluminux Clinical Research has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM), Overweight.

Sponsors: Pfizer, Alpine Immune Sciences Inc, A Subsidiary of Vertex, Atom Therapeutics Co., Ltd.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Naperville

Browse all research sites in Illinois · View every site in Naperville

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bioluminux Clinical Research?

Bioluminux Clinical Research has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bioluminux Clinical Research conducted?

Bioluminux Clinical Research has 4 clinical trials on record, with 3 currently active. Their work covers Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM), Overweight.

Is Bioluminux Clinical Research accredited by Crixeo Clinical Trials?

Bioluminux Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bioluminux Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.